Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
– 86 . Google Scholar OpenURL Placeholder Text WorldCat Weisman MH , Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, et al. Efficacy , pharmacokinetic , and safety assessment of adalimumab ...
The aims of this randomized, double‐blind, three‐arm, single‐dose study were to demonstrate pharmacokinetic (PK) equivalence of the adalimumab biosimilar M923 (hereafter referred to as “M923 ...
: 439 – 447 . Google Scholar PubMed WorldCat 16. Weisman MH , Moreland LW , Furst DE , et al. . Efficacy , pharmacokinetic , and safety assessment of adalimumab , a fully human anti-tumor necrosis factor ...
Events Open in new tab Table 3. Adverse Events Open in new tab Discussion This prospective multicenter observational cohort study assessed the efficacy and safety of adalimumab dose escalation up to 80 mg ...
concentrations and clinical outcomes was assessed using data from CLinical Assessment of Adalimumab Safety and Efficacy Studied as Induction Therapy in Crohn's Disease (CLASSIC) I/II. Methods Serum adalimumab ...
, Moreland LW , Furst DE et al. Efficacy , pharmacokinetic , and safety assessment of adalimumab , a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving ...
. Several studies have confirmed that biosimilar infliximab is comparable to its originator in terms of efficacy , safety , and pharmacokinetic properties.2–5 Adalimumab has been available to treat Crohn’s ...
Background The aim of this meta-analysis was to explore the magnitude of the association between pharmacokinetics of adalimumab and clinical response in patients with inflammatory bowel disease ...
Introduction The objective of this study was to demonstrate that BCD-057 is similar to innovator adalimumab (iADA) in terms of efficacy , safety , and pharmacokinetics in steady state in the target ...
. Weisman MH , Moreland LW , Furst DE , et al. Efficacy , pharmacokinetic , and safety assessment of adalimumab , a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!